circRNA basic information
circBase ID: hsa_circ_0005883
Name: hsa_circ_MYBL1
Synonym: circMYBL1
Host Gene: MYBL1
Genomic location(hg19): chr8:67504674-67514758:-
Genomic location(hg38): chr8:66592439-66602523:-
Subcellular localization: nucleus and cytoplasm; extracellular vesicle
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0004971
MONDO name: adenoid cystic carcinoma
Disease details: Adenoid cystic carcinoma
Disease DO ID:
0080202
Disease MeSH ID:
D003528
Disease NCIt ID:
C2970
Disease ICD11 ID:
2127202862
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

ACC tissues; adjacent nontumor tissues; submandibular gland tissues; plasma sEVs; lung tissues

Cell lines:

SACC-83; SACC-LM; HPMEC; primary SMG cells; HaCaT; HN6; SCC25; MCF7; HeLa

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: CEBPB, CD44, EIF3E, CD44 promoter
Associated microRNA: -
Biological function: circMYBL1 promotes malignant phenotypes of ACC cells, enhances migration, invasion, sphere formation, colony formation, anoikis resistance, adhesion between ACC cells and pulmonary endothelial cells, tumor cell arrest, and lung metastasis.
Molecular mechanism: circMYBL1 forms a circRNA-protein complex with CEBPB, inhibits ubiquitin-mediated degradation of CEBPB, promotes CEBPB nuclear translocation, increases CEBPB binding to the CD44 promoter, enhances CD44 transcription, and can be transmitted via sEVs to promote ACC lung metastasis.
Biological pathway or process:

metastasis (promotes); migration (promotes); invasion (promotes); proliferation (promotes); stemness (promotes); ubiquitination (inhibits); other pathway/process (promotes)

Detected method:
Q
M
Validation methods:

Microarray; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RNase R Treatment; RT-qPCR; FISH / smFISH; IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; ChIP / ChIP-seq; Transfection; Colony Formation Assay; Transwell Assay; Wound Healing Assay; Flow Cytometry(Non-apoptosis/cycle); Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis

Clinical significance:

High circMYBL1 expression is positively correlated with lung metastasis, tumor-node-metastasis stage, and poor cumulative survival; circMYBL1 may serve as a biomarker and therapeutic target for ACC.

Description:

circMYBL1 is a MYBL1-derived circRNA upregulated in salivary ACC tissues and plasma sEVs, and high expression is associated with lung metastasis and poor survival. It promotes ACC malignant phenotypes and lung metastasis by binding and stabilizing CEBPB, enhancing CEBPB nuclear translocation and CD44 transcription, and by sEV-mediated transfer that increases CD44-dependent adhesion between ACC cells and pulmonary endothelial cells.

Confidence score:

0.8973

Other information
Title:

Extracellular Vesicles Containing circMYBL1 Induce CD44 in Adenoid Cystic Carcinoma Cells and Pulmonary Endothelial Cells to Promote Lung Metastasis.

Journal: Cancer research
Published: 2024
PubMed ID: 38657100
Study type:

combined biological and clinical study

Data availability: GSE144660; GSE32465; GSE87418; GSE263601; GSE263719; GSE263444; Supplementary Tables S2, S3, S4, and S5; EV240013
Code availability: -